EVEROLIMUS EVERTOR 10MG - ANTICANCER DRUGS


Taishadarelene

Uploaded on Jul 22, 2019

Comments

                     

EVEROLIMUS EVERTOR 10MG - ANTICANCER DRUGS

EVEROLIMUS EVERTOR 10MG - ANTICANCER DRUGS | BIOCON | MHP M I L L I O N   H E A LT H   P H A R M AC E U T I C A L S DESCRIPTION • Evertor 10mg tablet consist of an active ingredient known as Everolimus which is intrude with growth of cancer cell and process is slows down.Evertor 10mg tablet is not a curable medication, which is helps to slow their spreading in to the body. EVERTOR PRESCRIBING INFORMATION • Primarily Evertor  10mg tablet indicated for the treatment kidney carcinoma Breast carcinoma Brain carcinoma Everolimus is also indicated in various advanced stage cancer in stomach, intestines or pancreas. EVERTOR MECHANISM • Everolimus is an inhibitor of mTOR, joins at high compatibility to FK506 binding protein 12, via producing drug complex that inhibits the productive of mTOR. This inhibition reduce the activity of effectors downstream, which may leads to stoppage of cell progression from G1 into S phase, Finally causes cell growth arrest and apoptosis  KIDNEY CARCINOMA ADME PROCESS • ABSORPTION The maximium plasma concentration time of Everolimus reaches within 1 to 2 hours. • DISTRIBUTION Albumin human plasma protein bound of 74%. • METABOLISM In hepatic Everolimus metabolism is occurred, which is a substrate of CYP3A4. The metabolites of Everolimus in 3 process; Three monohydroxylated metabolite, Two hydrolytic rings opened products, Phosphatidylcholine conjugate of Everolimus. • ELIMINATION half life period of Everolimus is 30 hours The elimination primarily via 5% in urine; the parent compound has been detected in urine or feces. PRODUCT DETAILS: Brand : Evertor  Ingredients : Everolimus  Strength : 10mg  Manufactured : Biocon  Package : 10 Tablets in a strip  DOSAGE REGIMEN • In breast cancer, renal cell cancer, pancreatic cancer, Neuro endocrine cancer: The prescribed dosage is 10mg should be taken as a single dose. In Brain or intracranial cancer: The prescribed dosage of Evertoras 10mg a single dose. is 4.5mg/m2 given orally In pediatric: The pediatric dosage of Evertor as a single dose in brain or intracranial tumor is 4.5mg/m2 should be given orally. OVER DOSAGE • The over dosage of Everolimus is limited, If over dosage occurs patient must be provide with supportive measures. And monitor evidence of toxicity in Everolimus over dosage WHEN TO TAKE THE DRUG EVERTOR • Evertor 10mg tablets should be given with or without food. EVERTOR CAUSED SIDE EFFECTS • Hypersensitivity reactions Lymphomas & other malignancy Serious infections Kidney graft thrombosis Hepatic artery thrombosis Nephrotoxicity Hyperlipemia Angioedema Interstitial lung disease Thrombocytopenia Male infertility Proteinuria New commencement of diabetes SAFETY PRECAUTIONS • LYMPHOMAS • Developed hazard of skin cancers, patient may protect from UV light • SERIOUS INFECTIONS • Patients getting Evertor 10mg have severe risk of achieve various infections related to bacteria, virus, and fungi HEPATIC ARTERY THROMBOSIS • Evertor 10ng tablet therapy should not be recommended in In liver transplant patients, • EMBRYO FETAL TOXICITY • using Evertor 10mg in pregnancy condition Causes fetal damage NEPHROTOXICITY • While using Evertor 10mg tablet in renal impaired patients Renal function should be monitored frequently; drug use with caution • INTERSTITIAL LUNG DISEASE • In Evertor 10mg therapy interstitial lung disease occur Blood glucose level should be monitored DRUG INTERACTION • Evertor  10mg tablet interaction with strong inhibitor of CYP3A4, or P-gp, cause reducing the efflux of Everolimus and high plasma concentration of Everolimus. Interaction of Evertor with strong CYP3A4 inducers, will increasing the disclosure of Everolimus. Combination ofEvertor with cyclosporine will increasing the AUC level of Everolimus frequently.  PREGNANCY & LACTATION • Pregnancy category of Everolimus C In patients Evertor is used only after knowing the benefits to the mother exceed the risk to fetus. Breast feeding should not be suggested CONTRAINDICATION • If patients are contraindicated to the components present in the Evertor 10mg tablet. Some anaphylactic reaction occurs. MISSED DOSE • If the dose is missed, consult with healthcare practitioner and follow the instructions given by them. Thereby missed dose should be avoid and follow the regular dosing schedule. CONTACT US: • MOBILE NO:  +91-9940472902 • E-MAIL:   [email protected] • WEBSITE URL:    https://millionpharma.com/evertor.php